Heart failure is a complex clinical syndrome affecting around 70 million individuals globally. It has a prevalence of 2% in ...

Drugs like gabapentin and pregabalin are known to cause fluid retention, leading to symptoms that doctors can confuse for ...

The outside advisors analyzed the results of the RELIEVE-HF pivotal trial, which randomized 508 patients to either receive ...

An FDA advisory panel gave a unanimous verdict for an interatrial shunt in heart failure: no way.

The FDA’s Circulatory System Devices Panel voted not to recommend approving use of an interatrial shunt to improve heart failure symptoms and prognosis.In a 0-15 vote, the committee determined risk ...

A genetic variant is likely putting some children suffering with myocarditis — inflammation of the heart muscle — at higher ...

J&J is pursuing premarket approval for the heart shunt. Although advisory committees provide recommendations to the FDA, the agency makes the final decisions. Following the vote, a J&J spokesperson ...

Capricor Therapeutics said Wednesday that its cell therapy significantly improved muscle and heart function in patients with ...

Ventura's permanent interatrial shunt was designed to shunt blood from the left to right atrium to improve symptoms in ...

Thanksgiving is a time for family, food, and tradition, but doctors say the holiday season is also one of the most dangerous ...

Guideline-recommended therapies for heart failure (HF) were found to be ineffective in patients with HF caused by Chagas ...

Abdominal fat is linked to changes in heart structure that can contribute to heart failure, German researchers reported in a ...